Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. DM Clinical Research — Tomball

Verified

Basic Information

Site Overview

Source: Human-provided.

DM Clinical Research is a leading integrated clinical research site network headquartered in Houston, Texas, that partners with pharmaceutical, biotechnology, and CRO organizations to conduct Phase I–IV clinical trials across a wide range of therapeutic areas, including vaccines, infectious diseases, cardiology, endocrinology, gastroenterology, neurology, psychiatry, women's health, pediatrics, and internal medicine. Founded in 2006, the organization has expanded to a nationwide network of more than 30 research locations, leveraging experienced investigators, advanced technology, and a diverse patient population to accelerate study enrollment and deliver high-quality, patient-centric research. With a strong focus on operational excellence, diversity, and innovation, DM Clinical Research enables faster, more inclusive clinical trial execution while providing participants with access to cutting-edge therapies under expert medical supervision.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Research institute

Business Subcategory

Source: Human-provided. Research institute
Source: Human-provided. Medical clinic
Source: Trial-derived.
15Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
10Completed Trials
Source: Trial-derived.
23Unique Conditions
Source: Trial-derived.
10Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Migraine (2)Source: Trial-derived. SARS-CoV-2 (2)Source: Trial-derived. Acute Gastroenteritis (1)Source: Trial-derived. Arthritis (1)Source: Trial-derived. Autoimmune Diseases (1)Source: Trial-derived. Chikungunya Virus Infection (1)Source: Trial-derived. Chronic Obstructive Pulmonary Disease (COPD) (1)Source: Trial-derived. Connective Tissue Diseases (1)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (4)Source: Trial-derived. Novo Nordisk A/S (3)Source: Trial-derived. Pfizer (2)Source: Trial-derived. AbbVie (1)Source: Trial-derived. Biohaven Therapeutics Ltd. (1)Source: Trial-derived. BioNTech SE (1)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. Expedition Therapeutics, Inc (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Ophthalmological retinopathy examination